ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,522.30
      1.58%
      US Tech 100
      19,014.40
      3.90%
      Dow Jones
      40,842.79
      0.24%
      Brent Oil
      81.255
      -0.31%
      Bitcoin
      64,348.51
      -0.39%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. BlackRock TCP Capital Corporation (TCPC) Quote

      BlackRock TCP Capital Corporation

      BlackRock TCP Capital Corporation (TCPC)

      NASDAQ
      10.57
      -0.08
      (-0.75%)
      Closed July 31 4:00PM
      Delayed by 15 minutes
      10.57
      -0.01
      (-0.09%)
      After Hours: 6:55PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      10.57
      Bid
      10.55
      Ask
      10.70
      Volume
      304,209
      10.56 Day's Range 10.713
      9.90 52 Week Range 13.00
      Market Cap
      904.698M
      Previous Close
      10.65
      Open
      10.70
      Last Trade
      3
      @
      10.7
      Last Trade Time
      Financial Volume
      $ 3,234,472
      VWAP
      10.6324
      Average Volume (3m)
      351,792
      Shares Outstanding
      85,591,134
      Dividend Yield
      12.87%
      PE Ratio
      23.54
      Earnings Per Share (EPS)
      0.45
      Revenue
      209.33M
      Net Profit
      38.47M

      About BlackRock TCP Capital Corporation

      BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve our investment obje... BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve our investment objective primarily through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments. Show more

      Sector
      Unit Inv Tr, Closed-end Mgmt
      Industry
      Unit Inv Tr, Closed-end Mgmt
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      BlackRock TCP Capital Corporation is listed in the Unit Inv Tr, Closed-end Mgmt sector of the NASDAQ with ticker TCPC. The last closing price for BlackRock TCP Capital was $10.65. Over the last year, BlackRock TCP Capital shares have traded in a share price range of $ 9.90 to $ 13.00.

      BlackRock TCP Capital currently has 85,591,134 shares outstanding. The market capitalization of BlackRock TCP Capital is $911.55 million. BlackRock TCP Capital has a price to earnings ratio (PE ratio) of 23.54.

      TCPC Latest News

      More News

      Alnylam Pharmaceuticals is Selling Off Today -- But Why?

      http://www.fool.com/investing/general/2015/12/07/alnylam-pharmaceuticals-is-selling-off-today-heres.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub

      December 07 2015
      The Motley Fool

      The Top 3 Biotech ETFs on the Market

      http://www.fool.com/investing/general/2015/11/01/the-top-3-biotech-etfs-on-the-market.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub

      November 01 2015
      The Motley Fool

      Biotechnology ETF Investing 101 - ETF News And Commentary

      With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector...

      May 20 2013
      Zacks

      Is the Biotech Sector Still a Market Leader? - Real Time Insight

      The biotechnology sector has been a strong performer for much of 2013. The space has seen huge gains over and above that of the broad market, with biotech benchmarks outpacing the S&P 500...

      April 25 2013
      Zacks

      Gilead Puts Biotech ETFs in Focus - ETF News And Commentary

      California-based Gilead Sciences (GILD) was in focus last week as it saw some encouraging clinical trial data on its HIV pill—TAF. This report pushed up GILD by about 4.5% last week and...

      March 11 2013
      Zacks

      Two Sector ETFs to Buy in 2013 - ETF News And Commentary

      In the current uncertain economic environment with ultra low interest rates, investors have been starved for income in 2012. Investors in search of a decent level of current income have...

      January 11 2013
      Zacks

      Top Ranked Biotech ETF: FBT - ETF News And Commentary

      With the economy poised to jump over the fiscal cliff in just a few days, investors are becoming all the more cautious as the risks are high for the U.S. economy to slip into another recession...

      December 24 2012
      Zacks

      Biotech ETFs: A Fiscal Cliff Safe Haven? - ETF News And Commentary

      With the election over, many investors assumed that one of the key risk events for U.S. markets was past us. However, this certainly hasn’t been the case, as the election worries were...

      November 16 2012
      Zacks

      The Five Best ETFs over the Past Five Years - ETF News And Commentary

      In the last five years, investors have witnessed a variety of market conditions. Stocks were relatively strong in the middle part of 2007 but, as we all know, proceeded to fall apart during the...

      July 02 2012
      Zacks

      Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary

      Recent earnings reports from a few bellwethers in the pharmaceutical space suggest that more pain is likely ahead for the beleaguered industry. Both Pfizer (PFE) and Eli Lilly (LLY) managed to...

      February 09 2012
      Zacks
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.19-1.7657992565110.7610.8710.5623752910.72517182CS
      4-0.39-3.5583941605810.9611.05510.5625628310.83873758CS
      120.020.18957345971610.5511.51510.4635179210.92209991CS
      26-1.01-8.721934369611.5811.69.943329610.60710254CS
      52-1.63-13.360655737712.2139.937913311.09976248CS
      156-3.74-26.135569531814.3114.529.628423911.97077637CS
      260-3.54-25.088589652714.1115.074.0230730511.73717271CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NCNCnoco noco Inc
      $ 0.28
      (83.01%)
      		299.32M
      WINTWindtree Therapeutics Inc
      $ 9.19
      (61.80%)
      		682.68k
      NUZENuZee Inc
      $ 5.915
      (59.86%)
      		36.61M
      PMECPrimech Holdings Ltd
      $ 0.8299
      (57.72%)
      		99.13M
      LSHLakeside Holding Ltd
      $ 3.70
      (56.12%)
      		28.51M
      CETUUCetus Capital Acquisition Corporation
      $ 2.60
      (-62.86%)
      		3.1k
      CETUCetus Capital Acquisition Corporation
      $ 2.22
      (-62.18%)
      		537.72k
      IMNNImunon Inc
      $ 1.33
      (-59.94%)
      		16.24M
      FGENFibroGen Inc
      $ 0.5417
      (-47.41%)
      		16.48M
      VCNXVaccinex Inc
      $ 5.09
      (-36.85%)
      		1.06M
      NVDANVIDIA Corporation
      $ 117.02
      (12.81%)
      		473.3M
      NCNCnoco noco Inc
      $ 0.28
      (83.01%)
      		299.33M
      SQQQProShares UltraPro Short QQQ
      $ 8.59
      (-8.91%)
      		244.35M
      PRSTPresto Technologies Inc
      $ 0.038406
      (9.73%)
      		207.14M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.343
      (8.54%)
      		145.24M

      Discussion

      View Full Feed
      Monterey2000 Monterey2000 33 seconds ago
      My3sons, Here are the projections made during the 2024 1st Qtr Earnings call..
      Looking forward to Q2, we expect recurring revenue will include $93 million to $97 million of revenue from existing contracts plus any amounts we recognize from any new agreements we may sign over the balance of t
      IDCC
      janice shell janice shell 39 seconds ago
      WSJ reporter Evan Gershkovich may be released as part of prisoner exchange, Russian media reports

      That would be good. And something else Biden and Kamala could take credit for.
      cojoboy cojoboy 43 seconds ago
      He has to kiss her ass..I learned the hard way..imo
      IGPK
      Hercules1 Hercules1 59 seconds ago
      https://x.com/JohnZidar/status/1818791202063298903
      HIRU
      Hercules1 Hercules1 2 minutes ago
      https://x.com/radiowavesss/status/1818804877671158265
      HIRU
      cojoboy cojoboy 2 minutes ago
      The idea here is to make money...some of us do..so of us post long winded nonsense..smh.
      RONN
      Zardiw Zardiw 3 minutes ago
      $NCNC +116%+ #DDAmanda Video Analysis - #1 Stock Scanner/Screener

      https://www.youtube.com/watch?v=40LFaeQtrBw

      Z
      NCNC
      Hercules1 Hercules1 3 minutes ago
      https://x.com/Prince_Cali_619/status/1818810265602789807
      HIRU
      burner67 burner67 3 minutes ago
      Wow
      BEGI
      Zardiw Zardiw 3 minutes ago
      $NCNC +116%+ #DDAmanda Video Analysis - #1 Stock Scanner/Screener

      https://www.youtube.com/watch?v=40LFaeQtrBw

      Z
      NCNC
      Zardiw Zardiw 4 minutes ago
      $NCNC +116%+ #DDAmanda Video Analysis - #1 Stock Scanner/Screener

      https://www.youtube.com/watch?v=40LFaeQtrBw

      Z
      NCNC
      LetGoodTimesRoll LetGoodTimesRoll 4 minutes ago
      BELIEVE IT!!!!

      "Moving forward

      We began 2024 with positive operational momentum and seek to build on recent achievements to: (i) further expand our healthcare services offerings in the communities we serve, (ii) consider options to reopen or create value from our close
      RNVA
      Zardiw Zardiw 4 minutes ago
      $NCNC +116%+ #DDAmanda Video Analysis - #1 Stock Scanner/Screener

      https://www.youtube.com/watch?v=40LFaeQtrBw

      Z
      NCNC
      cojoboy cojoboy 4 minutes ago
      Don't know what to make of that.????..smh
      RONN
      JonDoe1 JonDoe1 5 minutes ago
      That doesn't make AABB a legitimate company and that's a small peanut of their entire portfolio. Financial advisors also make mistakes.
      AABB
      TRUISM TRUISM 6 minutes ago
      Commonality is discontinuing...

      https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse4.mm.bing.net%2Fth%3Fid%3DOIP.VpHAGdwHaVOojzEtApWE2AHaCh%26pid%3DApi&f=1&ipt=92335d2f11269c3d8262efec2f76c8a886821b7470267e029e69604533401d32&ipo=images
      KBLB
      Midwestrader Midwestrader 6 minutes ago
      LOL...that's the THIRD annual report that Willy has now filed. What hasn't been filed is the required Attorney letter by the SEC. Oh wait,where are the Q1 financials?? NEVER FILED and not even a late filing notice.

      Guess what.... the Q2's are due in two weeks.

      The ONL
      JADA
      Drugdoctor Drugdoctor 6 minutes ago
      LMAO - the SEC has NOT made Sharp return any shares to CalASSe. The lower courts have ruled he got them illegally, and he keeps appealing and that's what the NEVADA SUPREME COURT will have to decide now. Sheesh, what a lying bunch of swill you have spewed upon this great board!
      WNFT
      MasterBlastr MasterBlastr 6 minutes ago
      So what about the worm?
      NWBO
      katiesdad7 katiesdad7 8 minutes ago
      I wouldn’t expect to hear anything till mid August at the earliest. The government moves very, very slow and nothing’s going to happen until the symbol change. This makes sense. You don’t want to sign contracts under the old name, but once it happens, it’s going to happen quickly.
      ECSL
      DewDiligence DewDiligence 8 minutes ago
      OSTX IPOs 1.84M* shares @$4.00:

      https://www.businesswire.com/news/home/20240731616879/en OS Therapies is a clinical stage oncology company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.

      OST-
      blackhawks blackhawks 9 minutes ago
      Exceptional compilation, thanks.
      surfer44 surfer44 9 minutes ago
      Either more ideas or we wait for the Company's feedback.
      WinstonCup WinstonCup 9 minutes ago
      There was NO way on getting your money back. Who knows where the money went. Now they are saying we get equal shares of WDLF. Let's see, that's .0004 compared to 2.50 a share. Yeah, I'd say that's a loss.
      imo
      WDLF

      Your Recent History

      NASDAQ
      TCPC
      BlackRock TCP Capital
      BIT
      NSCIT5410CA9
      Italy
      Delayed Upgrade Clock